NCT02210065 Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation Status COMPLETED Phase PHASE2
NCT02192333 Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors Status COMPLETED Phase NA
NCT02187133 Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1
NCT02178722 Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT02169505 Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT) Status TERMINATED Phase PHASE2
NCT02167958 Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source Status COMPLETED Phase PHASE1
NCT02145559 A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02130869 A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT02129049 Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children Status COMPLETED Phase NA
NCT02108444 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients Status COMPLETED Phase N/A
NCT02107443 Improving Communication in Older Cancer Patients and Their Caregivers Status COMPLETED Phase NA
NCT02106988 Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02095951 Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection Status COMPLETED Phase PHASE4
NCT02091063 ACY-1215 for Relapsed/Refractory Lymphoid Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT02082626 Study of Eribulin in Children With Cancer to Determine Safety Status TERMINATED Phase PHASE1
NCT02076451 Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT02072655 Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization Status COMPLETED Phase NA
NCT02065154 Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis Status COMPLETED Phase PHASE2